We and others have identified luteinizing hormonereleasing hormone (LHRH) in cells of the immune system in both animals and humans. LHRH is an immunostimulant, and testosterone is an immunosuppressant. Because testosterone is known to modulate the concentrations of hypothalamic LHRH, we wondered whether testosterone might also alter the concentrations of rat thymic LHRH. Two weeks after castration or sham castration, adult male rats were implanted with either vehicle or testosterone capsules. All animals were killed 4 days after capsule implantation. Thymic LHRH concentration increased significantly in castrated animals. Testosterone replacement prevented this increase. The concentration of the LHRH precursor, proLHRH, decreased significantly, but testosterone replacement prevented this decrease. Steady-state concentrations of LHRH mRNA were not changed by castration or by hormonal replacement. In contrast to the post-castration increase in thymic LHRH, LHRH content of the hypothalamus decreased significantly. Whereas concentrations of LHRH were lower in the thymus than in the hypothalamus, proLHRH concentrations were much greater in the thymus. These data suggest that gonadal manipulation modulates LHRH molecular processing and its tissue concentration in the thymus in addition to those in the hypothalamus, and that the regulation of LHRH molecular processing by testosterone in the hypothalamus is different from that in the thymus.
Introduction
Recent reports have demonstrated that luteinizing hormone-releasing hormone (LHRH), in addition to having a pivotal role in regulating the hypothalamicpituitary-gonadal axis, is an immunmodulator. Our laboratory and others have shown that LHRH is produced and processed in human and rat lymphocytes (Emanuele et al. 1990 , Azad et al. 1991a ,b, 1993 . Moreover, many studies have demonstrated that LHRH has a significant stimulatory effect on T cell proliferative activity and other aspects of immune function (Marchetti et al. 1989a ,b, Azad et al. 1990a , Batticane et al. 1991 , Jacobson et al. 1994 . Furthermore, the immunosuppressive effect of gonadal hormones, mainly testosterone, has been known for several decades (Wyle & Kent 1977 , Grossman et al. 1983 , Grossman 1984 , Blagosklonny & Neckers 1994 . The thymus gland, which is the major source of T lymphocyte production and has been shown to produce LHRH (Azad et al. 1991a) , decreases in size and function after sexual maturation (Weksler et al. 1978 , Makinodan & Kirokawa 1985 . However, castration before puberty delays postpubertal thymic involution and preserves T cell proliferative activity (Castro 1974 , Weksler et al. 1978 . The presence of testosterone (Kovacs & Olsen 1987) and dihydrotestosterone (Grossman et al. 1979 , McCruden & Stimson 1981 , Meikle et al. 1991 receptors, and the demonstration that gonadal hormones can be metabolized in thymic lymphocytes, further support an immunomodulator role of gonadal steroids (Weinstein et al. 1977 , Sholiton et al. 1980 .
Because gonadal steroids modify the concentrations of hypothalamic LHRH (Roselli et al. 1990) , the following experiments were designed to study the effect of castration and testosterone replacement on the production and molecular processing of thymic LHRH, and to compare those results with the effect of the same manipulations on hypothalamic LHRH.
Materials and Methods

Animals
Castrated and sham-castrated male Sprague-Dawley rats, 60-70 days old, were obtained from Harlan SpragueDawley (Indianapolis, IN, USA). The rats were housed in groups of two or three at a temperature of 22 2 C and with a 12 h light/12 h darkness cycle. Food and water were available ad libitum.
Procedure
Gonadectomy was performed using standard methods. Male rats, 60 days old, were anesthetized with pentobarbital (1 mg/kg) i.p. The scrotal sac was cleaned with alcohol and a small incision of approximately 2 cm was made midsagittally at the scrotal septum. The spermatic cords were dissected, tied and cut. The testes were carefully removed from the scrotal sac. The incision was sutured. In sham operations, the scrotal incisions were immediately sutured and the gonadal system was not manipulated. The entire procedure was performed under aseptic conditions. Animals were allowed to recover from the anesthesia and, when they were able to eat and drink, they were returned to the animal quarters.
Two weeks after castration, castrated rats were implanted s.c. with a silastic capsule containing either vehicle or testosterone and the sham-castrated rats were implanted with vehicle capsules only. Testosterone (CIBA, Summit, NJ, USA) capsules were made using Silastic tubing (inside diameter 0·062 mm; outside diameter 0·125 mm) purchased from Dow-Corning (Midland, MI, USA). The animals were killed 96 h after the implantation of the silastic capsules (Azad et al. 1990b) .
The data presented were pooled from several experiments, and do not contain equal numbers of animals in each case presented. Data were not arbitrarily discarded. Some thymuses were analyzed for LHRH mRNA by reverse transcription (RT)-PCR; some were used for LHRH assay and some were used to assay the precursor of LHRH, proLHRH. Because of shortages of proLHRH antibody at the time of the experiment, we were not able to analyze all of the thymuses for proLHRH.
Processing of tissues
The rats were killed by decapitation, and the hypothalamus and thymus were quickly dissected out. Trunk blood was collected, and serum stored at 20 C. The tissues used to assay proLHRH RNA were immediately placed in liquid nitrogen, then stored at 70 C.
To process the tissues for RIA, the thymuses were immediately weighed and homogenized in chilled 0·01 M PBS, pH 7·4, at a concentration of 25 mg/ml, using a Tekmar tissuemizer. They then were centrifuged at 2000 r.p.m. (1720 g) for 30 min in a Sorvall RC-5B refrigerated centrifuge, and the supernatant kept at 20 C until required for RIA. On the day of the RIA, the supernatant was thawed and filtered using a 25-mm syringe filter unit (PGC Scientific, Gaithersburg, MD, USA). After removal from the animals, the hypothalami were immediately frozen in liquid nitrogen and kept at 70 C. On the day of the RIA, the hypothalami were thawed and homogenized with a Tekmar tissuemizer in chilled 0·01 M PBS, pH 7·4, at a concentration of 1 hypothalamus/ml, centrifuged in the same way as thymuses, and supernatant taken for RIA the same day. All the tissue processing was performed on ice.
On the basis of experience gained in our laboratory, this method of tissue processing for LHRH and proLHRH RIA was demonstrated to be much simpler, yet yielded the same amount of peptides in RIA compared with other methods of tissue preparation for LHRH and proLHRH.
LHRH and proLHRH RIA
The LHRH RIA was conducted, as described previously (Azad et al. 1993) , using antiserum (CRR11B73) graciously supplied by Dr Victor Ramirez of the University of Illinois (Champaign-Urbana, IL, USA). The assay sensitivity was 15·6 pg/ml (3·1 pg/tube), and the intra-and interassay coefficients of variation were 5·1% and 15% respectively.
ProLHRH RIA was performed using antiserum and proLHRH for standard and iodination kindly supplied by Dr John P Adelman, Oregon Health Sciences University (Portland, OR, USA) as previously described (Azad et al. 1993) . ARK2 antiserum specifically recognizes the proLHRH molecule and was directed against amino acid residues 6-16, which span the cleavage site between LHRH and LHRH-related peptide in the proLHRH molecule. This antiserum has virtually no cross reactivity with the mature LHRH peptide (Roselli et al. 1990) . The sensitivity of the assay was 78 pg/ml, and the intra-and interassay coefficients of variation were 4% and 12% respectively.
Testosterone RIA
Testosterone RIA was performed using a kit purchased from Pantex (Pantex, Santa Monica, CA, USA). The sensitivity of the assay was 2 pg, equivalent to 0·1 ng/ml in serum, and the intra-and interassay coefficients of variation were 8% and 12% respectively.
Reverse transcription-polymerase chain reaction
The following primer pairs were used in these experiments: LHRH (exon 2) 5 -GCCAATTCAAAAACTC CTAGCTGGCC-3 , LHRH (exon 4) 5 -ATCTTCTT CTGCCCAGTTTCCTCTT-3 . The expected product of 375 bp was produced after PCR amplification. The histone H3·3 primers produced a PCR product of 213 bp.
RNA isolation, reverse transcription-polymerase chain reaction
The methodology for semiquantitative or comparative RT-PCR has been previously described (Chomczynski & Sacchi 1987 , Azad et al. 1993 . Briefly, total RNA was extracted from the cells according to the procedure of Chomczynski & Sacchi (1987) as previously described. This procedure results in RNA isolation without genomic DNA contamination. Three micrograms of total RNA were added to a reaction tube containing 50 mM Tris-HCl (pH 8·3), 75 mM KCl, 3 mM MgCl 2 , 10 mM dithiothreitol, 2 mM of each deoxynucleotide triphosphate (dNTP), 10 U RNasin (RNase inhibitor, Promega, Madison, WI, USA), 100 pmol oligo-(dT) primers (Bethesda Research Laboratories, Gaithersburg, MD, USA), and RNase-free deionized distilled water to a final volume of 19 µl. This mixture was heated for 10 min at 65 C and quenched on ice, then 200 U Moloney murine leukemia virus RNase-H reverse transcriptase (Superscript, Bethesda Research Laboratories) in 1 µl were added to give a total reaction volume of 20 µl. This mixture was incubated at room temperature for 10 min, and then at 42 C for 1 h. The reaction was terminated by heating at 95 C for 5 min and quenching on ice. RNase-H (2 U) was then added to the reaction and incubated for 20 min at 37 C. Five microliters of the reverse transcription reaction from each sample were diluted into a final volume of 100 µl in 10 mM Tris-HCl (pH 8·3), 50 mM KCl, 1·5 mM MgCl 2 , 200 µM each of deoxynucleotide triphosphate, 0·01% gelatin, 0·01% Tween-20, 0·01% Nonidet P-40, 2 µM of each oligonucleotide, and 2 U Taq-thermostable polymerase (Epicentre, Madison, WI, USA). The polymerase amplification was carried out using an MJ Research programmable heating/cooling dry block for 23 cycles of amplification (94 C, 30 s; 60 C, 1 min; 72 C, 2 min), followed by 10 min at 72 C. Negative controls were run in parallel, and consisted of a reaction performed as described above, but without the addition of reverse transcriptase. PCR products labeled with phosphorus-32 were transferred to nytram paper, then exposed to radiographic film. The density of the PCR product on film was measured by densitometer and expressed as arbitrary densitometry units (ADU).
Statistical analysis
A one-way ANOVA was applied to analyze the effect of gonadal manipulation on hypothalamic and thymic LHRH and proLHRH. Tukey's test was used for multiple comparisons between the three experimental groups: sham-castrated, castrated, and castrated replaced with testosterone.
Results
To confirm the effect of gonadal manipulation on serum testosterone, sera of several randomly selected rats were studied. The overall effect of gonadal manipulation was significant by ANOVA (P<0·001). The serum concentration of testosterone decreased from 3·78 0·6 ng/ml (n=5) in sham-castrated animals, to 1·05 0·2 ng/ml (n=5 ) in castrated animals (P<0·01). The serum testosterone concentration in testosterone-replaced animals was 3·72 0·3 ng/ml (n=4), essentially identical to that in the sham-operated group and significantly greater than that seen in the castrated group (P<0·01).
The effects of gonadectomy and testosterone replacement on thymic LHRH concentration (the amount of LHRH per mg of tissue) and molecular processing from proLHRH to LHRH were studied. Two weeks after surgery, sham-castrated rats were implanted with vehicle capsules and castrated rats were implanted with testosterone or vehicle capsules; animals were killed 96 h later.
The overall effect of gonadal manipulation on thymic LHRH concentration was significant (P<0·0026 by ANOVA). The thymic LHRH concentration increased from 3·1 0·3 pg/mg tissue (n=23) in sham-castrated animals to 6 0·95 pg/mg tissue (n=18) 2 weeks after castration (P=0·05). Thymic LHRH concentration returned to that observed in the sham-operated rats (3·1 0·4 pg/mg tissue; n=10) when gonadectomized rats were treated with testosterone ( Fig. 1, upper panel) . This value was not different from that in sham-castrated rats, but it was significantly lower than the LHRH concentration seen in gonadectomized, non-testosterone-replaced animals (P=0·05).
The overall effect of gonadal manipulation on thymic proLHRH concentration was significant by ANOVA (P<0·024). Thymic proLHRH concentration decreased from 77·4 10·3 pg/mg tissue (n=12) in sham-castrated rats to 43 4 pg/mg tissue (n=11) in castrated animals (P=0·05). Testosterone replacement restored thymic proLHRH to 80·4 16·8 pg/mg tissue (n=7; P=0·05 compared with castrated, vehicle-replaced rats), which did not differ from the concentration in sham-castrated rats (Fig. 1, lower panel) . Thymic proLHRH concentration changed in a direction opposite to that observed for LHRH.
The overall effect of gonadal manipulation on thymic weight was highly significant by ANOVA (P<0·0001). As expected, thymic weight increased (from 440 19 mg (n=15) in sham-castrated rats to 793 26 mg (n=12) in castrated animals, P<0·001; Fig. 2 ). Testosterone replacement reduced thymus weight to 662 22 mg (n=14), which was significantly lower than that in castrated animals (P<0·001), but still higher than that in sham-castrated animals (Fig. 2) .
The overall effect of gonadal manipulation on total thymic LHRH content (total amount of LHRH in whole thymus) in this experiment was significant by ANOVA (P<0·0025). Total thymic LHRH content increased from 1537 133 pg (n=14) in sham-castrated animals to 3832 826 pg (n=12) in castrated animals (P<0·01).
Ninety-six hours after testosterone replacement, the thymic content of LHRH in castrated animals decreased to 1564 147 pg (n=10; P<0·01 compared with castrated, non-testosterone-replaced animals; Fig. 3, upper panel) . Changes in thymic proLHRH content in the various experimental groups were in the same direction as those in thymic proLHRH concentration, but did not reach statistical significance (Fig. 3, lower panel) .
We also examined the effect of castration and testosterone replacement on LHRH mRNA expression in the thymus (Fig. 4) . Because of large differences in LHRH mRNA expression in individual animals, the effect of gonadal manipulation did not reach statistical significance. The density of PCR product increased from 469 23 ADU in intact rats (n=4) to 605 204 ADU (n=3) in gonadectomized rats. Testosterone treatment restored this value to 483 54 ADU (n=4).
The overall effect of gonadal manipulation on hypothalamic LHRH was significant (P<0·0024 by ANOVA). Total hypothalamic LHRH content decreased from 2809 37 pg/hypothalamus (n=10) in sham-operated rats, to 1949 197 pg/hypothalamus (n=7) in castrated animals (P=0·05). Testosterone replacement increased hypothalamic LHRH to 2487 140 pg/hypothalamus (n=5; P=0·05 compared with castrated, non-testosteronereplaced rats), which did not differ from the value in sham-castrated rats (Fig. 5 upper panel) . The hypothalamic content of proLHRH was not significantly changed by experimental manipulation: it was 580 69 pg/hypothalamus (n=14) in sham-operated animals, 558 96 pg/hypothalamus (n=7) in rats 2 weeks after castration, and 406 16 pg/hypothalamus (n=8) in castrated animals treated with testosterone (Fig. 5, lower  panel) .
Discussion
Several lines of evidence support an immunostimulatory role for LHRH. Immunoreactive and bioactive LHRH has been demonstrated to be present in rat and human T lymphocytes (Emanuele et al. 1990 , Azad et al. 1991a ,b, 1993 . In addition, demonstration of the presence of proLHRH mRNA in these tissues confirms local synthesis (Azad et al. 1991 (Azad et al. , 1993 . The presence of LHRH receptor sites on lymphocytes has been reported in several species (Marchetti et al. 1989a , Standaert et al. 1992 . Immunologic stimulation with phytohemagglutinin or antireceptor antibody significantly increased T cell LHRH production in human and rat T cells (Azad et al. 1990a, 1993 and unpublished observations) . This upregulation is PKC-and tyrosine kinase-dependent (Mohagheghpour et al. 1995) . It has been shown that LHRH agonist increased T cell proliferative activity of rat splenic and thymic lymphocytes (Emanuele et al. 1990 , Azad et al. 1991a ,b, 1993 . Chronic treatment with an LHRH agonist regenerated the involuted thymus gland in aged rats and improved the compromised T cell proliferative activity in aged female and male rats (Marchetti et al. 1989b) . Furthemore, LHRH agonist treatment increased interleukin-2 receptor expression in resting and conconavalin-A-treated thymic and splenic lymphocytes (Batticane et al. 1991) .
It has also been demonstrated that LHRH has an important role in an immunostimulated state. LHRH antagonist administration to lupus-prone mice decreased antibody production and hematuria, and significantly increased the animals' life spans ( Jacobson et al. 1994) , suggesting that this autoimmune state is, in part, dependent upon excessive expression of immune cell LHRH.
Testosterone, a testicular androgen, had been shown to be an immunosuppressor (Grossman 1984) . Castration of prepubertal male rats delayed involution of the thymus gland (Castro 1974 , Weksler et al. 1978 . In addition, castration during senescence reversed the age-related loss of cell-mediated immunity (Chiodi 1976) , but administration of testosterone prevented this process (Ablin et al. 1974 , Chiodi 1976 , Grossman 1984 , Kelley et al. 1988 . Dihydrotestosterone (DHT), the active metabolite of testosterone, and testosterone itself had inhibitory effects on the production of various antibodies and retarded the progression of autoimmune disdorders in N2B/NZW mice (Steinberg et al. 1979) . A recent study demonstrated that testosterone and DHT reverse the castration-induced expansion of pre-B cells in bone marrow, and that this effect was independent of the thymus gland (Kovacs et al. 1996) .
We have shown for the first time that testosterone modulated thymic proLHRH and LHRH concentrations. The concentration of LHRH in the thymus gland increased after castration, whereas proLHRH decreased. These effects were totally prevented by replacement with testosterone ( Fig. 1) . Similarly, LHRH content increased after castration, an effect again totally prevented by testosterone replacement (Fig. 3) . The decreased proLHRH and increased LHRH, coupled with unchanged LHRH mRNA in castrated rats, indicate that testosterone acted post-translationally to inhibit processing of LHRH from its precursor molecule, proLHRH.
Our studies, in agreement with the findings of many previous investigations (Grossman 1984 , Marchetti et al. 1989b , showed significant enlargement in the size of the thymus gland after castration and partial inhibition of this increase in thymic size with testosterone replacement (Fig. 2) . Considering the known immunostimulatory effect of LHRH on T cells, our data are consistent with the hypothesis that the increased concentrations of LHRH in the thymus gland of castrated rats might have played a significant part in thymus growth and T cell development of these animals.
The inhibitory effect of testosterone on thymic LHRH concentrations, coupled with the well-known immunosuppressive effect of testosterone, suggest that the mechanism of the inhibitory role of testosterone on the immune system may be, in part, achieved by its diminishing the concentrations of LHRH in lymphocytes.
The second objective of this study was to compare the effect of castration and testosterone replacement on hypothalamic LHRH with their effect on thymic LHRH. In accordance with the observations of others (Roselli et al. 1990) , our data showed that castration significantly decreased hypothalamic LHRH content, by 31%, and that testosterone replacement restored hypothalamic LHRH to sham control values (Fig. 5) . This is in direct contrast to the effect on the thymus, indicating markedly different, organ-specific regulatory patterns.
Finally, this is the first report examining the relative contents of LHRH in the hypothalamus and immune tissue. Our data showed comparable concentrations of LHRH in the two tissues, but a much greater content of proLHRH in the thymus. It is thus tempting to speculate that neuroendocrine and immune tissues may possess marked differences in their rates of processing of proLHRH to LHRH. Future investigations are required to examine this issue.
In summary, castration increased the thymic concentration of LHRH, and decreased thymic proLHRH, whereas testosterone treatment prevented these effects. In contrast, the hypothalamic concentration of LHRH was significantly decreased in castrated rats, but normalized with testosterone treatment. In addition, the thymus contains much more proLHRH, but less LHRH, than the hypothalamus. These data suggest that gonadal manipulation modulates thymic LHRH molecular processing and its tissue concentration, in addition to that in the hypothalamus, and that the regulation of LHRH molecular processing by testosterone is different in the hypothalamus and in the thymus.
